AI-powered robotics system will increase access to diagnostic imaging, improving patient care
Robotics company Cobionix has raised a $2.8 million seed round to deploy its commercial robotics system Codi, an industry-first tele-robotic medical imaging tool.
The Velocity company hopes that Codi will increase access to diagnostic imaging services and save healthcare costs by reducing procedure time, ultimately improving patient care.
“The healthcare field is suffering from a major skilled labour shortage, and we are very excited to help alleviate this problem with autonomous robotic technology that will result in decreased wait times, lower procedure costs and directly improve patient care,” said Dr. Tim Lasswell MD, co-founder of Cobionix.
CEO Nima Zamani (pictured, centre) said the company’s goal is to combine state-of-the-art robotic hardware with state-of-the-art artificial intelligence to create a seamless robot to human interaction without the user needing high knowledge of engineering or coding.
Since joining Velocity in the spring of 2021, Cobionix has built a functional product, and passed a milestone audit necessary to manufacture medical devices.
“At Velocity we built a clinical-grade commercial product,” Zamani said. “It is one of the few incubators that are supporting medical device development and we’ve used the space, support, mentorship, and access to investors — Velocity has helped us in many areas.”
Read the full story here.Learn more about Velocity companies